tert-Butyl 4-amino-2,2-dimethylpiperidine-1-carboxylate

Catalog No. :
ACOCSG627
CAS No. :
1361396-89-5
Molecular Formula :
C12H24N2O2
Molecular Weight :
228.34

IUPAC Name:tert-butyl 4-amino-2,2-dimethylpiperidine-1-carboxylate

tert-Butyl 4-amino-2,2-dimethylpiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$72.00Login to see priceIn stockIn stock
250mg95%$118.00Login to see priceIn stockIn stock
1g95%$380.00Login to see priceIn stockIn stock
5g95%$1862.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-amino-2,2-dimethylpiperidine-1-carboxylate
IUPAC Nametert-butyl 4-amino-2,2-dimethylpiperidine-1-carboxylate
MDL No.MFCD22394504
Molecular FormulaC12H24N2O2
Molecular Weight228.34
SMILESO=C(N1C(C)(C)CC(N)CC1)OC(C)(C)C
InChI KeyXEDCFYKXFOXJOD-UHFFFAOYSA-N
Synonymtert-Butyl 4-amino-2,2-dimethyl-1-piperidinecarboxylate;tert-butyl 4-amino-2,2-dimethylpiperidine-1-carboxylate;1-Piperidinecarboxylic acid, 4-amino-2,2-dimethyl-, 1,1-dimethylethyl ester;4-Amino-2,2-dimethyl-piperidine-1-carboxylic acid tert-butyl ester;1-Boc-4-amino-2,2-dimethylpiperidine
CAS No.1361396-89-5
PubChem CID57936262

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACOCSG627 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQIAC103 route compound structure diagram
    ACQIAC103346593-03-1 In Stock
  2. Then
  3. ACOCSG627 route product structure diagram
    ACOCSG6271361396-89-5 In Stock
Inquiry

2. ACOCSG627 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOCSG627 route product structure diagram
    ACOCSG6271361396-89-5 In Stock
Inquiry

Comments (0)